Universal Insurance Holdings Combined Ratios Below 100% Challenge Bearish Profitability Narratives

Universal Insurance Holdings, Inc. +1.22% Post

Universal Insurance Holdings, Inc.

UVE

34.13

34.13

+1.22%

0.00% Post

Universal Insurance Holdings FY 2025 Earnings Snapshot

Universal Insurance Holdings (UVE) has wrapped up FY 2025 with fourth quarter total revenue of US$407.9 million and basic EPS of US$2.40, alongside net income of US$66.6 million as investors weigh these results against a year where net profit margin moved from 3.9% to 11.4% and earnings growth was very large at about 210.5% year over year. Over recent periods the company has seen total revenue shift from US$384.8 million and basic EPS of US$0.21 in Q4 2024 to US$407.9 million and US$2.40 in Q4 2025. Trailing twelve month EPS moved from US$2.07 on US$1.5b of revenue to US$6.56 on US$1.6b of revenue. With analysts expecting earnings to decline about 22.8% per year over the next three years, even as net margin now sits in double digits, this print sets up a results season where the sustainability of recent profitability will be front of mind for investors.

See our full analysis for Universal Insurance Holdings.

With the headline numbers on the table, the next step is to see how this earnings run lines up with the prevailing stories around UVE, where some long held views may be confirmed while others get pushed back by the data.

NYSE:UVE Revenue & Expenses Breakdown as at Feb 2026
NYSE:UVE Revenue & Expenses Breakdown as at Feb 2026

Combined ratios back under 100% in 2025

  • Across 2025, the combined ratio sat between 95% and 97.8% in the first three quarters, compared with 116.9% in Q3 2024 and 104.1% on a trailing basis at Q4 2024, which lines up with the move in net margin from 3.9% to 11.4% over the last year.
  • Consensus narrative points to technology and data use as a help for underwriting, and the recent ratios give some backing to that bullish angle but also show areas to watch:
    • The 95% to 97.8% range in 2025 suggests underwriting has been tighter than the 116.9% combined ratio in Q3 2024, which fits the view that better risk selection and claims handling can support margins over time.
    • At the same time, the fact that the trailing combined ratio was 104.1% at Q4 2024 shows how quickly catastrophe costs and reinsurance terms can affect results, which ties into the bearish concern around higher ceded premium costs and loss ratios.
Over 2025 the underwriting math has looked a lot healthier than it did in late 2024, and that tug of war between improving combined ratios and past spikes in costs is exactly what bulls and bears are both focused on. 🐂 Universal Insurance Holdings Bull Case

Trailing EPS above US$6 vs forecasts of slower profit

  • On a trailing basis, EPS at Q4 2025 was US$6.56 with net income of US$182.9 million on US$1.6b of revenue, while the provided forecasts point to earnings of US$105.8 million and EPS of US$3.43 by about 2028 and an expected earnings decline of about 22.8% per year over the next three years in one set of estimates.
  • Bears focus on these lower forward numbers, and the gap to the recent trailing figures gives their argument some clear support:
    • Reported earnings growth over the last year was very large at about 210.5% with net margin at 11.4%, yet forecasts in the data set call for earnings to shrink by around 22.8% per year and revenue to dip about 1.8% per year, which fits the bearish view that recent profitability may not be repeated.
    • The same dataset also notes analysts expecting profit margins at 7.2% in three years versus 4.2% in another snapshot, which sits below the current 11.4% net margin and feeds the bearish concern that higher loss and expense ratios as well as reinsurance costs could pressure returns compared with the latest twelve month run rate.
Skeptical investors are asking whether US$6.56 of trailing EPS is a high watermark, and the forecast path back toward roughly US$3.43 by 2028 is a big part of that debate. 🐻 Universal Insurance Holdings Bear Case

P/E of 5x and DCF fair value at about US$53.96

  • With the share price at US$32.70, the trailing P/E sits around 5x compared with a US insurance industry average of 12.1x and a peer average of 25.1x, and the DCF fair value of US$53.96 is roughly 39% above the current price while the allowed analyst price target reference is US$40.00.
  • Consensus narrative leans on valuation support, and the numbers here both back that stance and bring in some tension from the risk side:
    • The gap between a 5x P/E and higher industry and peer multiples aligns with the reward framing that the stock trades at a lower valuation, especially with net margin at 11.4% and trailing EPS of US$6.56 on US$1.6b of revenue.
    • At the same time, the risk section highlighting expected earnings declines of about 22.8% per year and modest revenue pressure of about 1.8% per year shows why the market might be cautious even with a DCF fair value at US$53.96 and an allowed target reference of US$40.00 on the table.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Universal Insurance Holdings on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of strong recent numbers and cautious forecasts feels like a split story, take a moment to weigh it yourself. You may want to move quickly while the data is fresh, starting with 4 key rewards and 2 important warning signs.

See What Else Is Out There

UVE's recent profitability sits against forecasts calling for roughly 22.8% yearly earnings declines and softer margins, which raises questions about how consistent its returns might be.

If that earnings uncertainty has you wanting steadier potential, you may want to quickly check out 80 resilient stocks with low risk scores to focus on companies with more resilient profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.